Why You should choose Life Science?

 Life science industry stands for area of biotechnology and its connection with the business. It is a sector where the knowledge about living organism and their potential is used in industry in order to increase healthcare, find new solutions, or decrease the cost of potential treatment. This zone involves biotechnology, pharmacy, biomedical technologies, nutraceuticals, cosmetology, food processing, ecology, many doctors, specialists, but finally it connects all of those spheres in business in order to commercialize of products, innovative solutions and technologies.

The potential of Life Science that is hidden is huge. Scientists around the world work on the products that would improve living, health care or just technologies that would be innovative, less expensive, easier in performing, more efficient or safer. The development and the progress of life science is highly correlate with global gross domestic product (GDP) growth and for last few years the dynamization is visible.

Gil Granot-Mayer underline the problems that lies behind the life science brand. The investment is huge, the risk that project fail is high. That pushes back the potential investors. Potential businessman should be prepared that the time of return may be very, very long and takes more than 5 and even 10 years. Over 20 – 30 years took the project to be visible real revenue of the transfer, their success comes even later. Thus came the lesson for potential investors – to invest their money for a long time. Considering commercialization of technologies, products and results of researches it is very important to understand the market and the request. Investors look for breakthrough scientific invention and expected products that would be promising, thus the scientists should take care about the patent protection of their product.

Regarding investments, there is great diversity, and the businessman can choose proper for their expectation the area to put the money in. Also they may invest at the same time in many areas to increase the possibilities of success. It would reduce risk than having only one project even it is extremely promising and successful. Moreover, during creating the start ups, scientists or venture capitalists should look for potential partner that know the brand or have a minimum experience in the market. All of those actions that would minimize the opportunity of failure should push forward the investors.

Despite the innovative solutions and the significant improvements market and the investors are still conservative and have an approach with high dose of distance and lack of trust constitute an obstacle that is not easy to jump. This is the main, basal mistake and greatest problem. From the other hand for investors is extremely difficult to assess the potential risk and the value of innovation if they do not know the market and requests of field. To meet concerns we should focus on promises, progress and innovations. There are about 1000 companies in Europe (and the number is still raising) that working in life science brand. Their success should be signpost for all that still have doubts. 

Sources:
http://www.fractal.org/Life-Science-Technology/Definition.htm
https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/dttl-lshc-2014-global-life-sciences-sector-report.pdf
Elia Giovacchini, Priority Sector Report: Life Science, Insphere March 2011 – deliverable D9-3.

Hanna Banasiak